| Mapoly0001s0311 |
[PTHR15131] SMALL NUCLEAR RNA ACTIVATING COMPLEX, POLYPEPTIDE 1; [PF09808] Small nuclear RNA activating complex (SNAPc), subunit SNAP43 |
|
| Mapoly0001s0529 |
[GO:0055114] oxidation-reduction process; [GO:0005515] protein binding; [1.13.11.12] Linoleate 13S-lipoxygenase.; [GO:0016702] oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; [PTHR11771] LIPOXYGENASE; [PF01477] PLAT/LH2 domain; [GO:0046872] metal ion binding; [K00454] lipoxygenase [EC:1.13.11.12]; [PF00305] Lipoxygenase |
|
| Mapoly0004s0298 |
[KOG1187] Serine/threonine protein kinase; [PF07714] Protein tyrosine kinase; [GO:0004672] protein kinase activity; [GO:0006468] protein phosphorylation; [PTHR24420] LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE |
|
| Mapoly0020s0024 |
[GO:0005524] ATP binding; [KOG0198] MEKK and related serine/threonine protein kinases; [PF00069] Protein kinase domain; [GO:0004672] protein kinase activity; [GO:0006468] protein phosphorylation; [PTHR24361] MITOGEN-ACTIVATED KINASE KINASE KINASE |
|
| Mapoly0020s0073 |
[PF05602] Cleft lip and palate transmembrane protein 1 (CLPTM1); [PTHR21347] CLEFT LIP AND PALATE ASSOCIATED TRANSMEMBRANE PROTEIN-RELATED; [KOG2489] Transmembrane protein; [PTHR21347:SF0] SUBFAMILY NOT NAMED |
|
| Mapoly0032s0088 |
[PF13450] NAD(P)-binding Rossmann-like domain; [GO:0055114] oxidation-reduction process; [PTHR15944] FAMILY NOT NAMED; [GO:0016670] oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor; [1.8.3.5] Prenylcysteine oxidase.; [PF07156] Prenylcysteine lyase; [GO:0030328] prenylcysteine catabolic process; [K05906] prenylcysteine oxidase [EC:1.8.3.5] |
|
| Mapoly0033s0005 |
[PTHR10281] MEMBRANE-ASSOCIATED PROGESTERONE RECEPTOR COMPONENT-RELATED; [GO:0020037] heme binding; [PF00173] Cytochrome b5-like Heme/Steroid binding domain; [KOG1110] Putative steroid membrane receptor Hpr6.6/25-Dx |
|
| Mapoly0039s0103 |
[KOG0143] Iron/ascorbate family oxidoreductases; [GO:0055114] oxidation-reduction process; [PF14226] non-haem dioxygenase in morphine synthesis N-terminal; [GO:0016706] oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; [PTHR10209] OXIDOREDUCTASE, 2OG-FE(II) OXYGENASE FAMILY PROTEIN; [GO:0016491] oxidoreductase activity; [PF03171] 2OG-Fe(II) oxygenase superfamily |
|
| Mapoly0041s0097 |
[K14395] lysophosphatidic acid phosphatase type 6 [EC:3.1.3.2]; [GO:0003993] acid phosphatase activity; [KOG3720] Lysosomal & prostatic acid phosphatases; [PTHR11567] ACID PHOSPHATASE-RELATED; [PF00328] Histidine phosphatase superfamily (branch 2); [3.1.3.2] Acid phosphatase. |
|
| Mapoly0046s0007 |
[PTHR11266:SF12] PXMP2-MPV17-RELATED; [PF04117] Mpv17 / PMP22 family; [GO:0016021] integral to membrane; [PTHR11266] PEROXISOMAL MEMBRANE PROTEIN 2, PXMP2 (MPV17); [KOG1944] Peroxisomal membrane protein MPV17 and related proteins |
|
| Mapoly0053s0067 |
- |
|
| Mapoly0062s0028 |
[PF05096] Glutamine cyclotransferase; [PTHR31270:SF0] SUBFAMILY NOT NAMED; [PTHR31270] FAMILY NOT NAMED |
|
| Mapoly0080s0018 |
- |
|
| Mapoly0082s0086 |
[PTHR11711] ADP RIBOSYLATION FACTOR-RELATED; [K07953] GTP-binding protein SAR1 [EC:3.6.5.-]; [3.6.5.-] Acting on GTP; involved in cellular and subcellular movement.; [PF00025] ADP-ribosylation factor family; [KOG0077] Vesicle coat complex COPII, GTPase subunit SAR1; [GO:0005622] intracellular; [GO:0006886] intracellular protein transport; [PTHR11711:SF12] GTP-BINDING PROTEIN SAR1; [GO:0005525] GTP binding |
|
| Mapoly0090s0082 |
[PF00026] Eukaryotic aspartyl protease; [K08245] phytepsin [EC:3.4.23.40]; [PF05184] Saposin-like type B, region 1; [3.4.23.40] Phytepsin.; [PTHR13683] ASPARTYL PROTEASES; [PF03489] Saposin-like type B, region 2; [GO:0004190] aspartic-type endopeptidase activity; [GO:0006508] proteolysis; [GO:0006629] lipid metabolic process |
|
| Mapoly0097s0079 |
[PTHR10992] ALPHA/BETA HYDROLASE FOLD-CONTAINING PROTEIN; [PF12697] Alpha/beta hydrolase family |
|
| Mapoly0099s0020 |
- |
|
| Mapoly0122s0009 |
[KOG1542] Cysteine proteinase Cathepsin F; [GO:0008234] cysteine-type peptidase activity; [PF08246] Cathepsin propeptide inhibitor domain (I29); [PF00112] Papain family cysteine protease; [PTHR12411] CYSTEINE PROTEASE FAMILY C1-RELATED; [GO:0006508] proteolysis |
|
| Mapoly0146s0004 |
[KOG1577] Aldo/keto reductase family proteins; [PTHR11732] ALDO/KETO REDUCTASE; [PF00248] Aldo/keto reductase family |
|
| Mapoly0163s0010 |
[PTHR24067] UBIQUITIN-CONJUGATING ENZYME E2; [GO:0016881] acid-amino acid ligase activity; [GO:0019789] SUMO ligase activity; [KOG0424] Ubiquitin-protein ligase; [6.3.2.19] Ubiquitin--protein ligase.; [K10577] ubiquitin-conjugating enzyme E2 I [EC:6.3.2.19]; [PTHR24067:SF51] SUMO-CONJUGATING ENZYME UBC9; [PF00179] Ubiquitin-conjugating enzyme |
|
| Mapoly0206s0010 |
[K00025] malate dehydrogenase [EC:1.1.1.37]; [PF00056] lactate/malate dehydrogenase, NAD binding domain; [GO:0055114] oxidation-reduction process; [KOG1496] Malate dehydrogenase; [PTHR23382] MALATE DEHYDROGENASE; [PF02866] lactate/malate dehydrogenase, alpha/beta C-terminal domain; [GO:0016491] oxidoreductase activity; [GO:0016616] oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; [1.1.1.37] Malate dehydrogenase.; [GO:0006108] malate metabolic process; [GO:0016615] malate dehydrogenase activity |
|